nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Rash—Carmustine—hematologic cancer	0.000223	0.000252	CcSEcCtD
Flumazenil—Ill-defined disorder—Prednisone—hematologic cancer	0.000223	0.000251	CcSEcCtD
Flumazenil—Dermatitis—Carmustine—hematologic cancer	0.000223	0.000251	CcSEcCtD
Flumazenil—Vomiting—Alitretinoin—hematologic cancer	0.000223	0.000251	CcSEcCtD
Flumazenil—Paraesthesia—Triamcinolone—hematologic cancer	0.000223	0.000251	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—hematologic cancer	0.000223	0.000251	CcSEcCtD
Flumazenil—Feeling abnormal—Prednisolone—hematologic cancer	0.000222	0.000251	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—hematologic cancer	0.000222	0.000251	CcSEcCtD
Flumazenil—Headache—Carmustine—hematologic cancer	0.000222	0.00025	CcSEcCtD
Flumazenil—Dyspnoea—Triamcinolone—hematologic cancer	0.000221	0.00025	CcSEcCtD
Flumazenil—Rash—Alitretinoin—hematologic cancer	0.000221	0.000249	CcSEcCtD
Flumazenil—Agitation—Prednisone—hematologic cancer	0.000221	0.000249	CcSEcCtD
Flumazenil—Dermatitis—Alitretinoin—hematologic cancer	0.000221	0.000249	CcSEcCtD
Flumazenil—Vomiting—Ifosfamide—hematologic cancer	0.00022	0.000248	CcSEcCtD
Flumazenil—Hypersensitivity—Cisplatin—hematologic cancer	0.00022	0.000248	CcSEcCtD
Flumazenil—Tachycardia—Dexamethasone—hematologic cancer	0.00022	0.000248	CcSEcCtD
Flumazenil—Tachycardia—Betamethasone—hematologic cancer	0.00022	0.000248	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—hematologic cancer	0.00022	0.000248	CcSEcCtD
Flumazenil—Headache—Alitretinoin—hematologic cancer	0.00022	0.000248	CcSEcCtD
Flumazenil—Nausea—Thalidomide—hematologic cancer	0.000219	0.000247	CcSEcCtD
Flumazenil—Rash—Ifosfamide—hematologic cancer	0.000219	0.000246	CcSEcCtD
Flumazenil—Dermatitis—Ifosfamide—hematologic cancer	0.000218	0.000246	CcSEcCtD
Flumazenil—Hyperhidrosis—Betamethasone—hematologic cancer	0.000218	0.000246	CcSEcCtD
Flumazenil—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000218	0.000246	CcSEcCtD
Flumazenil—Dizziness—Irinotecan—hematologic cancer	0.000218	0.000245	CcSEcCtD
Flumazenil—Urticaria—Etoposide—hematologic cancer	0.000217	0.000245	CcSEcCtD
Flumazenil—Malaise—Prednisone—hematologic cancer	0.000217	0.000244	CcSEcCtD
Flumazenil—Vertigo—Prednisone—hematologic cancer	0.000216	0.000243	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—hematologic cancer	0.000215	0.000243	CcSEcCtD
Flumazenil—Hypoaesthesia—Epirubicin—hematologic cancer	0.000215	0.000242	CcSEcCtD
Flumazenil—Vomiting—Vincristine—hematologic cancer	0.000215	0.000242	CcSEcCtD
Flumazenil—Urticaria—Prednisolone—hematologic cancer	0.000214	0.000242	CcSEcCtD
Flumazenil—Asthenia—Cisplatin—hematologic cancer	0.000214	0.000242	CcSEcCtD
Flumazenil—Fatigue—Triamcinolone—hematologic cancer	0.000214	0.000241	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—hematologic cancer	0.000213	0.000241	CcSEcCtD
Flumazenil—Rash—Vincristine—hematologic cancer	0.000213	0.00024	CcSEcCtD
Flumazenil—Dermatitis—Vincristine—hematologic cancer	0.000213	0.00024	CcSEcCtD
Flumazenil—Pain—Triamcinolone—hematologic cancer	0.000212	0.000239	CcSEcCtD
Flumazenil—Headache—Vincristine—hematologic cancer	0.000212	0.000239	CcSEcCtD
Flumazenil—Hypotension—Dexamethasone—hematologic cancer	0.00021	0.000237	CcSEcCtD
Flumazenil—Hypotension—Betamethasone—hematologic cancer	0.00021	0.000237	CcSEcCtD
Flumazenil—Nausea—Carmustine—hematologic cancer	0.00021	0.000237	CcSEcCtD
Flumazenil—Vomiting—Mitoxantrone—hematologic cancer	0.000209	0.000236	CcSEcCtD
Flumazenil—Vomiting—Irinotecan—hematologic cancer	0.000209	0.000236	CcSEcCtD
Flumazenil—Nausea—Alitretinoin—hematologic cancer	0.000208	0.000235	CcSEcCtD
Flumazenil—Visual impairment—Epirubicin—hematologic cancer	0.000208	0.000235	CcSEcCtD
Flumazenil—Hypertension—Prednisone—hematologic cancer	0.000208	0.000234	CcSEcCtD
Flumazenil—Rash—Irinotecan—hematologic cancer	0.000207	0.000234	CcSEcCtD
Flumazenil—Rash—Mitoxantrone—hematologic cancer	0.000207	0.000234	CcSEcCtD
Flumazenil—Dermatitis—Mitoxantrone—hematologic cancer	0.000207	0.000234	CcSEcCtD
Flumazenil—Dermatitis—Irinotecan—hematologic cancer	0.000207	0.000234	CcSEcCtD
Flumazenil—Chills—Methotrexate—hematologic cancer	0.000207	0.000233	CcSEcCtD
Flumazenil—Headache—Mitoxantrone—hematologic cancer	0.000206	0.000232	CcSEcCtD
Flumazenil—Headache—Irinotecan—hematologic cancer	0.000206	0.000232	CcSEcCtD
Flumazenil—Nausea—Ifosfamide—hematologic cancer	0.000206	0.000232	CcSEcCtD
Flumazenil—Feeling abnormal—Triamcinolone—hematologic cancer	0.000205	0.000231	CcSEcCtD
Flumazenil—Anxiety—Prednisone—hematologic cancer	0.000204	0.00023	CcSEcCtD
Flumazenil—Vomiting—Gemcitabine—hematologic cancer	0.000204	0.00023	CcSEcCtD
Flumazenil—Insomnia—Betamethasone—hematologic cancer	0.000204	0.00023	CcSEcCtD
Flumazenil—Insomnia—Dexamethasone—hematologic cancer	0.000204	0.00023	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—hematologic cancer	0.000203	0.000229	CcSEcCtD
Flumazenil—Paraesthesia—Betamethasone—hematologic cancer	0.000202	0.000228	CcSEcCtD
Flumazenil—Paraesthesia—Dexamethasone—hematologic cancer	0.000202	0.000228	CcSEcCtD
Flumazenil—Discomfort—Prednisone—hematologic cancer	0.000202	0.000228	CcSEcCtD
Flumazenil—Rash—Gemcitabine—hematologic cancer	0.000202	0.000228	CcSEcCtD
Flumazenil—Dermatitis—Gemcitabine—hematologic cancer	0.000202	0.000228	CcSEcCtD
Flumazenil—Hypersensitivity—Etoposide—hematologic cancer	0.000202	0.000227	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—hematologic cancer	0.000201	0.000227	CcSEcCtD
Flumazenil—Erythema—Methotrexate—hematologic cancer	0.000201	0.000226	CcSEcCtD
Flumazenil—Headache—Gemcitabine—hematologic cancer	0.000201	0.000226	CcSEcCtD
Flumazenil—Nausea—Vincristine—hematologic cancer	0.000201	0.000226	CcSEcCtD
Flumazenil—Flushing—Epirubicin—hematologic cancer	0.0002	0.000226	CcSEcCtD
Flumazenil—Hypersensitivity—Prednisolone—hematologic cancer	0.000199	0.000224	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000199	0.000224	CcSEcCtD
Flumazenil—Urticaria—Triamcinolone—hematologic cancer	0.000197	0.000222	CcSEcCtD
Flumazenil—Asthenia—Etoposide—hematologic cancer	0.000196	0.000221	CcSEcCtD
Flumazenil—Nausea—Mitoxantrone—hematologic cancer	0.000195	0.00022	CcSEcCtD
Flumazenil—Nausea—Irinotecan—hematologic cancer	0.000195	0.00022	CcSEcCtD
Flumazenil—Fatigue—Dexamethasone—hematologic cancer	0.000194	0.000219	CcSEcCtD
Flumazenil—Fatigue—Betamethasone—hematologic cancer	0.000194	0.000219	CcSEcCtD
Flumazenil—Chills—Epirubicin—hematologic cancer	0.000194	0.000218	CcSEcCtD
Flumazenil—Pruritus—Etoposide—hematologic cancer	0.000194	0.000218	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—hematologic cancer	0.000193	0.000217	CcSEcCtD
Flumazenil—Pain—Betamethasone—hematologic cancer	0.000193	0.000217	CcSEcCtD
Flumazenil—Pain—Dexamethasone—hematologic cancer	0.000193	0.000217	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—hematologic cancer	0.000193	0.000217	CcSEcCtD
Flumazenil—Tachycardia—Prednisone—hematologic cancer	0.000191	0.000216	CcSEcCtD
Flumazenil—Nausea—Gemcitabine—hematologic cancer	0.00019	0.000215	CcSEcCtD
Flumazenil—Vomiting—Cisplatin—hematologic cancer	0.00019	0.000214	CcSEcCtD
Flumazenil—Hyperhidrosis—Prednisone—hematologic cancer	0.00019	0.000214	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—hematologic cancer	0.000189	0.000213	CcSEcCtD
Flumazenil—Rash—Cisplatin—hematologic cancer	0.000188	0.000212	CcSEcCtD
Flumazenil—Dermatitis—Cisplatin—hematologic cancer	0.000188	0.000212	CcSEcCtD
Flumazenil—Erythema—Epirubicin—hematologic cancer	0.000188	0.000212	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—hematologic cancer	0.000186	0.00021	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—hematologic cancer	0.000186	0.00021	CcSEcCtD
Flumazenil—Feeling abnormal—Betamethasone—hematologic cancer	0.000186	0.000209	CcSEcCtD
Flumazenil—Feeling abnormal—Dexamethasone—hematologic cancer	0.000186	0.000209	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—hematologic cancer	0.000185	0.000209	CcSEcCtD
Flumazenil—Tension—Epirubicin—hematologic cancer	0.000184	0.000208	CcSEcCtD
Flumazenil—Hypersensitivity—Triamcinolone—hematologic cancer	0.000183	0.000206	CcSEcCtD
Flumazenil—Nervousness—Epirubicin—hematologic cancer	0.000183	0.000206	CcSEcCtD
Flumazenil—Malaise—Methotrexate—hematologic cancer	0.000181	0.000204	CcSEcCtD
Flumazenil—Dizziness—Etoposide—hematologic cancer	0.000181	0.000204	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—hematologic cancer	0.00018	0.000203	CcSEcCtD
Flumazenil—Chills—Doxorubicin—hematologic cancer	0.000179	0.000202	CcSEcCtD
Flumazenil—Urticaria—Dexamethasone—hematologic cancer	0.000179	0.000202	CcSEcCtD
Flumazenil—Urticaria—Betamethasone—hematologic cancer	0.000179	0.000202	CcSEcCtD
Flumazenil—Dizziness—Prednisolone—hematologic cancer	0.000179	0.000201	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—hematologic cancer	0.000179	0.000201	CcSEcCtD
Flumazenil—Asthenia—Triamcinolone—hematologic cancer	0.000178	0.000201	CcSEcCtD
Flumazenil—Nausea—Cisplatin—hematologic cancer	0.000177	0.0002	CcSEcCtD
Flumazenil—Insomnia—Prednisone—hematologic cancer	0.000177	0.0002	CcSEcCtD
Flumazenil—Vision blurred—Epirubicin—hematologic cancer	0.000177	0.0002	CcSEcCtD
Flumazenil—Paraesthesia—Prednisone—hematologic cancer	0.000176	0.000199	CcSEcCtD
Flumazenil—Pruritus—Triamcinolone—hematologic cancer	0.000176	0.000198	CcSEcCtD
Flumazenil—Cough—Methotrexate—hematologic cancer	0.000175	0.000198	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—hematologic cancer	0.000174	0.000197	CcSEcCtD
Flumazenil—Vomiting—Etoposide—hematologic cancer	0.000174	0.000196	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—hematologic cancer	0.000174	0.000196	CcSEcCtD
Flumazenil—Agitation—Epirubicin—hematologic cancer	0.000173	0.000195	CcSEcCtD
Flumazenil—Rash—Etoposide—hematologic cancer	0.000173	0.000195	CcSEcCtD
Flumazenil—Dermatitis—Etoposide—hematologic cancer	0.000172	0.000194	CcSEcCtD
Flumazenil—Headache—Etoposide—hematologic cancer	0.000171	0.000193	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—hematologic cancer	0.000171	0.000193	CcSEcCtD
Flumazenil—Tension—Doxorubicin—hematologic cancer	0.000171	0.000192	CcSEcCtD
Flumazenil—Rash—Prednisolone—hematologic cancer	0.00017	0.000192	CcSEcCtD
Flumazenil—Dermatitis—Prednisolone—hematologic cancer	0.00017	0.000192	CcSEcCtD
Flumazenil—Malaise—Epirubicin—hematologic cancer	0.00017	0.000191	CcSEcCtD
Flumazenil—Fatigue—Prednisone—hematologic cancer	0.000169	0.000191	CcSEcCtD
Flumazenil—Headache—Prednisolone—hematologic cancer	0.000169	0.000191	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—hematologic cancer	0.000169	0.00019	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—hematologic cancer	0.000169	0.00019	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—hematologic cancer	0.000169	0.00019	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000168	0.00149	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000168	0.00149	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000168	0.00149	CbGpPWpGaD
Flumazenil—Palpitations—Epirubicin—hematologic cancer	0.000166	0.000187	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—hematologic cancer	0.000165	0.000186	CcSEcCtD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000165	0.00146	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000165	0.00146	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000165	0.00146	CbGpPWpGaD
Flumazenil—Dizziness—Triamcinolone—hematologic cancer	0.000164	0.000185	CcSEcCtD
Flumazenil—Cough—Epirubicin—hematologic cancer	0.000164	0.000185	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—hematologic cancer	0.000164	0.000185	CcSEcCtD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000164	0.00145	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000164	0.00145	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000164	0.00145	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000164	0.00145	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.000163	0.00144	CbGpPWpGaD
Flumazenil—Nausea—Etoposide—hematologic cancer	0.000163	0.000183	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—hematologic cancer	0.000162	0.000183	CcSEcCtD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000162	0.00144	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK14—hematologic cancer	0.000162	0.00143	CbGpPWpGaD
Flumazenil—Feeling abnormal—Prednisone—hematologic cancer	0.000162	0.000182	CcSEcCtD
Flumazenil—Asthenia—Dexamethasone—hematologic cancer	0.000162	0.000182	CcSEcCtD
Flumazenil—Asthenia—Betamethasone—hematologic cancer	0.000162	0.000182	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—hematologic cancer	0.000161	0.000182	CcSEcCtD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000161	0.00142	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000161	0.00142	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000161	0.00142	CbGpPWpGaD
Flumazenil—Nausea—Prednisolone—hematologic cancer	0.00016	0.000181	CcSEcCtD
Flumazenil—Chest pain—Epirubicin—hematologic cancer	0.00016	0.00018	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—hematologic cancer	0.00016	0.00018	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—hematologic cancer	0.000159	0.00018	CcSEcCtD
Flumazenil—Pruritus—Dexamethasone—hematologic cancer	0.000159	0.00018	CcSEcCtD
Flumazenil—Pruritus—Betamethasone—hematologic cancer	0.000159	0.00018	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—hematologic cancer	0.000158	0.000179	CcSEcCtD
Flumazenil—Discomfort—Epirubicin—hematologic cancer	0.000158	0.000178	CcSEcCtD
Flumazenil—Vomiting—Triamcinolone—hematologic cancer	0.000158	0.000178	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—hematologic cancer	0.000157	0.000177	CcSEcCtD
Flumazenil—Rash—Triamcinolone—hematologic cancer	0.000157	0.000176	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—hematologic cancer	0.000157	0.000176	CcSEcCtD
Flumazenil—Dermatitis—Triamcinolone—hematologic cancer	0.000156	0.000176	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—hematologic cancer	0.000156	0.000176	CcSEcCtD
Flumazenil—Urticaria—Prednisone—hematologic cancer	0.000156	0.000176	CcSEcCtD
Flumazenil—Headache—Triamcinolone—hematologic cancer	0.000156	0.000175	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—NFKBIA—hematologic cancer	0.000155	0.00137	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—BAD—hematologic cancer	0.000155	0.00137	CbGpPWpGaD
Flumazenil—GABRA1—Orphan transporters—CREBBP—hematologic cancer	0.000155	0.00137	CbGpPWpGaD
Flumazenil—Confusional state—Epirubicin—hematologic cancer	0.000155	0.000174	CcSEcCtD
Flumazenil—GABRA5—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000155	0.00137	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—CAMK2D—hematologic cancer	0.000154	0.00136	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000154	0.00136	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000154	0.00136	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000154	0.00136	CbGpPWpGaD
Flumazenil—Palpitations—Doxorubicin—hematologic cancer	0.000154	0.000173	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—hematologic cancer	0.000153	0.000173	CcSEcCtD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000152	0.00135	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000152	0.00135	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000152	0.00134	CbGpPWpGaD
Flumazenil—Cough—Doxorubicin—hematologic cancer	0.000152	0.000171	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000151	0.00134	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.00015	0.00133	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.00015	0.00133	CbGpPWpGaD
Flumazenil—Hypertension—Doxorubicin—hematologic cancer	0.00015	0.000169	CcSEcCtD
Flumazenil—Tachycardia—Epirubicin—hematologic cancer	0.00015	0.000169	CcSEcCtD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.00015	0.00132	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000149	0.00132	CbGpPWpGaD
Flumazenil—Dizziness—Betamethasone—hematologic cancer	0.000149	0.000168	CcSEcCtD
Flumazenil—Dizziness—Dexamethasone—hematologic cancer	0.000149	0.000168	CcSEcCtD
Flumazenil—GABRA2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000149	0.00131	CbGpPWpGaD
Flumazenil—Hyperhidrosis—Epirubicin—hematologic cancer	0.000148	0.000167	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—hematologic cancer	0.000148	0.000167	CcSEcCtD
Flumazenil—GABRB3—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000148	0.00131	CbGpPWpGaD
Flumazenil—Chest pain—Doxorubicin—hematologic cancer	0.000148	0.000167	CcSEcCtD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000148	0.00131	CbGpPWpGaD
Flumazenil—Anxiety—Doxorubicin—hematologic cancer	0.000148	0.000166	CcSEcCtD
Flumazenil—GABRB3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000148	0.00131	CbGpPWpGaD
Flumazenil—Nausea—Triamcinolone—hematologic cancer	0.000147	0.000166	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—PTPN11—hematologic cancer	0.000147	0.0013	CbGpPWpGaD
Flumazenil—Paraesthesia—Methotrexate—hematologic cancer	0.000147	0.000166	CcSEcCtD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000147	0.0013	CbGpPWpGaD
Flumazenil—Discomfort—Doxorubicin—hematologic cancer	0.000146	0.000165	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—hematologic cancer	0.000146	0.000165	CcSEcCtD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000146	0.00129	CbGpPWpGaD
Flumazenil—Somnolence—Methotrexate—hematologic cancer	0.000146	0.000164	CcSEcCtD
Flumazenil—GABRG2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000146	0.00129	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000145	0.00128	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000145	0.00128	CbGpPWpGaD
Flumazenil—Dry mouth—Doxorubicin—hematologic cancer	0.000145	0.000163	CcSEcCtD
Flumazenil—Hypersensitivity—Prednisone—hematologic cancer	0.000145	0.000163	CcSEcCtD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000144	0.00128	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000144	0.00127	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000143	0.00127	CbGpPWpGaD
Flumazenil—Hypotension—Epirubicin—hematologic cancer	0.000143	0.000162	CcSEcCtD
Flumazenil—Vomiting—Betamethasone—hematologic cancer	0.000143	0.000161	CcSEcCtD
Flumazenil—Vomiting—Dexamethasone—hematologic cancer	0.000143	0.000161	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—hematologic cancer	0.000143	0.000161	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—FOS—hematologic cancer	0.000143	0.00127	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CREB1—hematologic cancer	0.000143	0.00126	CbGpPWpGaD
Flumazenil—Rash—Dexamethasone—hematologic cancer	0.000142	0.00016	CcSEcCtD
Flumazenil—Rash—Betamethasone—hematologic cancer	0.000142	0.00016	CcSEcCtD
Flumazenil—Dermatitis—Betamethasone—hematologic cancer	0.000142	0.00016	CcSEcCtD
Flumazenil—Dermatitis—Dexamethasone—hematologic cancer	0.000142	0.00016	CcSEcCtD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000142	0.00126	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000142	0.00125	CbGpPWpGaD
Flumazenil—Fatigue—Methotrexate—hematologic cancer	0.000141	0.000159	CcSEcCtD
Flumazenil—Headache—Dexamethasone—hematologic cancer	0.000141	0.000159	CcSEcCtD
Flumazenil—Headache—Betamethasone—hematologic cancer	0.000141	0.000159	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000141	0.00125	CbGpPWpGaD
Flumazenil—Asthenia—Prednisone—hematologic cancer	0.000141	0.000159	CcSEcCtD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000141	0.00124	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000141	0.00124	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000141	0.00124	CbGpPWpGaD
Flumazenil—Pain—Methotrexate—hematologic cancer	0.00014	0.000158	CcSEcCtD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000139	0.00123	CbGpPWpGaD
Flumazenil—Pruritus—Prednisone—hematologic cancer	0.000139	0.000156	CcSEcCtD
Flumazenil—Insomnia—Epirubicin—hematologic cancer	0.000139	0.000156	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—hematologic cancer	0.000139	0.000156	CcSEcCtD
Flumazenil—Paraesthesia—Epirubicin—hematologic cancer	0.000138	0.000155	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000137	0.000155	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—hematologic cancer	0.000137	0.000154	CcSEcCtD
Flumazenil—Somnolence—Epirubicin—hematologic cancer	0.000136	0.000154	CcSEcCtD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000135	0.0012	CbGpPWpGaD
Flumazenil—Feeling abnormal—Methotrexate—hematologic cancer	0.000135	0.000152	CcSEcCtD
Flumazenil—GABRA6—Neuronal System—PRKCG—hematologic cancer	0.000135	0.00119	CbGpPWpGaD
Flumazenil—Nausea—Dexamethasone—hematologic cancer	0.000134	0.000151	CcSEcCtD
Flumazenil—Nausea—Betamethasone—hematologic cancer	0.000134	0.000151	CcSEcCtD
Flumazenil—GABRA4—Neuronal System—PRKCG—hematologic cancer	0.000133	0.00118	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000133	0.00118	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAP2K1—hematologic cancer	0.000133	0.00117	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000133	0.00117	CbGpPWpGaD
Flumazenil—Hypotension—Doxorubicin—hematologic cancer	0.000133	0.00015	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—hematologic cancer	0.000132	0.000149	CcSEcCtD
Flumazenil—GABRA4—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000131	0.00116	CbGpPWpGaD
Flumazenil—Pain—Epirubicin—hematologic cancer	0.000131	0.000148	CcSEcCtD
Flumazenil—GABRA6—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000131	0.00116	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00013	0.00115	CbGpPWpGaD
Flumazenil—Urticaria—Methotrexate—hematologic cancer	0.00013	0.000147	CcSEcCtD
Flumazenil—Dizziness—Prednisone—hematologic cancer	0.00013	0.000146	CcSEcCtD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00013	0.00115	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000129	0.00114	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000129	0.00114	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000129	0.00114	CbGpPWpGaD
Flumazenil—Insomnia—Doxorubicin—hematologic cancer	0.000128	0.000145	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000128	0.00113	CbGpPWpGaD
Flumazenil—Paraesthesia—Doxorubicin—hematologic cancer	0.000127	0.000144	CcSEcCtD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000127	0.00113	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000127	0.00113	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000127	0.00113	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000127	0.00113	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000127	0.00112	CbGpPWpGaD
Flumazenil—Dyspnoea—Doxorubicin—hematologic cancer	0.000127	0.000143	CcSEcCtD
Flumazenil—GABRA4—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000127	0.00112	CbGpPWpGaD
Flumazenil—Feeling abnormal—Epirubicin—hematologic cancer	0.000126	0.000143	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—hematologic cancer	0.000126	0.000142	CcSEcCtD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000126	0.00112	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000126	0.00111	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000125	0.00111	CbGpPWpGaD
Flumazenil—Vomiting—Prednisone—hematologic cancer	0.000125	0.000141	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—PIK3R1—hematologic cancer	0.000124	0.0011	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000124	0.0011	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000124	0.0011	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000124	0.0011	CbGpPWpGaD
Flumazenil—Rash—Prednisone—hematologic cancer	0.000124	0.000139	CcSEcCtD
Flumazenil—Dermatitis—Prednisone—hematologic cancer	0.000124	0.000139	CcSEcCtD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000124	0.00109	CbGpPWpGaD
Flumazenil—Headache—Prednisone—hematologic cancer	0.000123	0.000139	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—hematologic cancer	0.000122	0.000138	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—hematologic cancer	0.000122	0.000137	CcSEcCtD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000122	0.00108	CbGpPWpGaD
Flumazenil—Pain—Doxorubicin—hematologic cancer	0.000121	0.000137	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000121	0.00107	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—JAK2—hematologic cancer	0.000121	0.00107	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000121	0.00107	CbGpPWpGaD
Flumazenil—Hypersensitivity—Methotrexate—hematologic cancer	0.000121	0.000136	CcSEcCtD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000119	0.00106	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000119	0.00105	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000118	0.00105	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—PRKCG—hematologic cancer	0.000118	0.00105	CbGpPWpGaD
Flumazenil—Asthenia—Methotrexate—hematologic cancer	0.000118	0.000133	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—hematologic cancer	0.000117	0.000132	CcSEcCtD
Flumazenil—GABRA5—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000117	0.00103	CbGpPWpGaD
Flumazenil—Nausea—Prednisone—hematologic cancer	0.000117	0.000131	CcSEcCtD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000116	0.00103	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—PRKCG—hematologic cancer	0.000116	0.00103	CbGpPWpGaD
Flumazenil—Pruritus—Methotrexate—hematologic cancer	0.000116	0.000131	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.000115	0.00102	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MTOR—hematologic cancer	0.000115	0.00102	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000115	0.00101	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000114	0.00101	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—PRKCG—hematologic cancer	0.000114	0.00101	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—PRKCG—hematologic cancer	0.000114	0.00101	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000113	0.001	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000113	0.001	CbGpPWpGaD
Flumazenil—Hypersensitivity—Epirubicin—hematologic cancer	0.000113	0.000127	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—hematologic cancer	0.000113	0.000127	CcSEcCtD
Flumazenil—GABRA2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000113	0.000996	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000112	0.000995	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000112	0.000995	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.000112	0.000992	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.000112	0.000991	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000112	0.00099	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000112	0.00099	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—PRKCG—hematologic cancer	0.000112	0.000987	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000111	0.000984	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000111	0.000984	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000111	0.000983	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.00011	0.000978	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00011	0.000978	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.00011	0.000977	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.00011	0.000975	CbGpPWpGaD
Flumazenil—Asthenia—Epirubicin—hematologic cancer	0.00011	0.000124	CcSEcCtD
Flumazenil—GABRG2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.00011	0.000972	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.00011	0.000971	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000109	0.000967	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000109	0.000966	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000109	0.000961	CbGpPWpGaD
Flumazenil—Pruritus—Epirubicin—hematologic cancer	0.000109	0.000122	CcSEcCtD
Flumazenil—GABRA2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000108	0.00096	CbGpPWpGaD
Flumazenil—Dizziness—Methotrexate—hematologic cancer	0.000108	0.000122	CcSEcCtD
Flumazenil—GABRB3—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000108	0.000959	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000108	0.000957	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000108	0.000956	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000108	0.000954	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000108	0.000954	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000107	0.000944	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000107	0.000943	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000106	0.000942	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000106	0.000941	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000106	0.000937	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CASP3—hematologic cancer	0.000106	0.000935	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000106	0.000935	CbGpPWpGaD
Flumazenil—Hypersensitivity—Doxorubicin—hematologic cancer	0.000105	0.000118	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—hematologic cancer	0.000104	0.000118	CcSEcCtD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000104	0.000918	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000104	0.000918	CbGpPWpGaD
Flumazenil—Rash—Methotrexate—hematologic cancer	0.000103	0.000117	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—hematologic cancer	0.000103	0.000116	CcSEcCtD
Flumazenil—Headache—Methotrexate—hematologic cancer	0.000103	0.000116	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—JUN—hematologic cancer	0.000103	0.000909	CbGpPWpGaD
Flumazenil—Asthenia—Doxorubicin—hematologic cancer	0.000102	0.000115	CcSEcCtD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000102	0.0009	CbGpPWpGaD
Flumazenil—Dizziness—Epirubicin—hematologic cancer	0.000101	0.000114	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—hematologic cancer	0.0001	0.000113	CcSEcCtD
Flumazenil—GABRA6—Neuronal System—CREB1—hematologic cancer	0.0001	0.000885	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—BRAF—hematologic cancer	9.87e-05	0.000874	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—CREB1—hematologic cancer	9.87e-05	0.000874	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.82e-05	0.000869	CbGpPWpGaD
Flumazenil—Vomiting—Epirubicin—hematologic cancer	9.76e-05	0.00011	CcSEcCtD
Flumazenil—GABRA4—Neuronal System—BRAF—hematologic cancer	9.75e-05	0.000863	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—PRKCG—hematologic cancer	9.75e-05	0.000863	CbGpPWpGaD
Flumazenil—Nausea—Methotrexate—hematologic cancer	9.74e-05	0.00011	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK8—hematologic cancer	9.71e-05	0.00086	CbGpPWpGaD
Flumazenil—Rash—Epirubicin—hematologic cancer	9.67e-05	0.000109	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—hematologic cancer	9.67e-05	0.000109	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.64e-05	0.000853	CbGpPWpGaD
Flumazenil—Headache—Epirubicin—hematologic cancer	9.61e-05	0.000108	CcSEcCtD
Flumazenil—GABRA1—Transmembrane transport of small molecules—NUP98—hematologic cancer	9.6e-05	0.000849	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.47e-05	0.000838	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—MDM2—hematologic cancer	9.47e-05	0.000838	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—CREB1—hematologic cancer	9.42e-05	0.000834	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.41e-05	0.000833	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.39e-05	0.000831	CbGpPWpGaD
Flumazenil—Dizziness—Doxorubicin—hematologic cancer	9.39e-05	0.000106	CcSEcCtD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	9.32e-05	0.000825	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—BRAF—hematologic cancer	9.3e-05	0.000823	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—MDM2—hematologic cancer	9.3e-05	0.000823	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.27e-05	0.000821	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—NUP214—hematologic cancer	9.25e-05	0.000819	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.24e-05	0.000818	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—SRC—hematologic cancer	9.21e-05	0.000815	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—MDM2—hematologic cancer	9.14e-05	0.000809	CbGpPWpGaD
Flumazenil—Nausea—Epirubicin—hematologic cancer	9.11e-05	0.000103	CcSEcCtD
Flumazenil—GABRB3—Transmission across Chemical Synapses—MDM2—hematologic cancer	9.08e-05	0.000804	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	9.06e-05	0.000802	CbGpPWpGaD
Flumazenil—Vomiting—Doxorubicin—hematologic cancer	9.03e-05	0.000102	CcSEcCtD
Flumazenil—Rash—Doxorubicin—hematologic cancer	8.95e-05	0.000101	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—hematologic cancer	8.94e-05	0.000101	CcSEcCtD
Flumazenil—GABRG2—Transmission across Chemical Synapses—MDM2—hematologic cancer	8.92e-05	0.000789	CbGpPWpGaD
Flumazenil—Headache—Doxorubicin—hematologic cancer	8.89e-05	0.0001	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—STAT3—hematologic cancer	8.88e-05	0.000786	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—CREB1—hematologic cancer	8.77e-05	0.000776	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—BRAF—hematologic cancer	8.66e-05	0.000767	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—CREB1—hematologic cancer	8.61e-05	0.000762	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	8.53e-05	0.000755	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	8.51e-05	0.000753	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—BRAF—hematologic cancer	8.51e-05	0.000753	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK3—hematologic cancer	8.48e-05	0.000751	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—CREB1—hematologic cancer	8.47e-05	0.000749	CbGpPWpGaD
Flumazenil—Nausea—Doxorubicin—hematologic cancer	8.43e-05	9.51e-05	CcSEcCtD
Flumazenil—GABRB3—Neuronal System—CREB1—hematologic cancer	8.41e-05	0.000744	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—BRAF—hematologic cancer	8.36e-05	0.00074	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—BRAF—hematologic cancer	8.31e-05	0.000735	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—MDM2—hematologic cancer	8.27e-05	0.000732	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—JUN—hematologic cancer	8.27e-05	0.000732	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—CREB1—hematologic cancer	8.26e-05	0.000731	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.24e-05	0.000729	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—MDM2—hematologic cancer	8.17e-05	0.000723	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—BRAF—hematologic cancer	8.16e-05	0.000722	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.09e-05	0.000716	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—TFRC—hematologic cancer	8.08e-05	0.000715	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.95e-05	0.000704	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.9e-05	0.000699	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	7.88e-05	0.000698	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.84e-05	0.000693	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—MDM2—hematologic cancer	7.8e-05	0.00069	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	7.78e-05	0.000689	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.76e-05	0.000686	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.74e-05	0.000685	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—EP300—hematologic cancer	7.62e-05	0.000675	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—MDM2—hematologic cancer	7.26e-05	0.000642	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	7.22e-05	0.000639	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—CREB1—hematologic cancer	7.22e-05	0.000639	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—BRAF—hematologic cancer	7.13e-05	0.000631	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—MDM2—hematologic cancer	7.13e-05	0.000631	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—MDM2—hematologic cancer	7e-05	0.00062	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—MDM2—hematologic cancer	6.96e-05	0.000616	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.91e-05	0.000612	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.87e-05	0.000608	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—MDM2—hematologic cancer	6.83e-05	0.000605	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.79e-05	0.000601	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.78e-05	0.0006	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.75e-05	0.000597	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.67e-05	0.000591	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.63e-05	0.000587	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.63e-05	0.000587	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.59e-05	0.000583	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.51e-05	0.000576	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—HRAS—hematologic cancer	6.48e-05	0.000574	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.47e-05	0.000573	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	6.19e-05	0.000548	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—MDM2—hematologic cancer	5.97e-05	0.000529	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.92e-05	0.000524	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.85e-05	0.000518	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	5.72e-05	0.000507	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	5.69e-05	0.000504	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.66e-05	0.000501	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.24e-05	0.000463	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.2e-05	0.00046	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.17e-05	0.000458	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.1e-05	0.000452	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.02e-05	0.000444	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	4.99e-05	0.000442	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.98e-05	0.000441	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ALB—hematologic cancer	4.9e-05	0.000434	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.89e-05	0.000433	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ALB—hematologic cancer	4.84e-05	0.000428	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.59e-05	0.000407	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—HRAS—hematologic cancer	4.54e-05	0.000402	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.51e-05	0.000399	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—HRAS—hematologic cancer	4.48e-05	0.000397	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.43e-05	0.000392	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.4e-05	0.00039	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.33e-05	0.000383	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	4.3e-05	0.000381	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.28e-05	0.000379	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	4.22e-05	0.000374	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	4.15e-05	0.000367	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	4.12e-05	0.000365	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	4.05e-05	0.000358	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—HRAS—hematologic cancer	3.98e-05	0.000352	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—HRAS—hematologic cancer	3.91e-05	0.000346	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—HRAS—hematologic cancer	3.84e-05	0.00034	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—HRAS—hematologic cancer	3.82e-05	0.000338	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.78e-05	0.000335	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—HRAS—hematologic cancer	3.75e-05	0.000332	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.54e-05	0.000313	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—HRAS—hematologic cancer	3.28e-05	0.00029	CbGpPWpGaD
